Tarsus Pharmaceuticals (TARS) Inventory Average: 2023-2025
Historic Inventory Average for Tarsus Pharmaceuticals (TARS) over the last 2 years, with Sep 2025 value amounting to $3.9 million.
- Tarsus Pharmaceuticals' Inventory Average rose 52.93% to $3.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.9 million, marking a year-over-year increase of 52.93%. This contributed to the annual value of $2.9 million for FY2024, which is N/A change from last year.
- According to the latest figures from Q3 2025, Tarsus Pharmaceuticals' Inventory Average is $3.9 million, which was up 17.19% from $3.3 million recorded in Q2 2025.
- In the past 5 years, Tarsus Pharmaceuticals' Inventory Average registered a high of $3.9 million during Q3 2025, and its lowest value of $1.6 million during Q4 2023.
- Its 3-year average for Inventory Average is $2.9 million, with a median of $2.9 million in 2024.
- Its Inventory Average has fluctuated over the past 5 years, first surged by 75.08% in 2024, then declined by 25.45% in 2025.
- Quarterly analysis of 3 years shows Tarsus Pharmaceuticals' Inventory Average stood at $1.6 million in 2023, then surged by 75.08% to $2.7 million in 2024, then surged by 52.93% to $3.9 million in 2025.
- Its last three reported values are $3.9 million in Q3 2025, $3.3 million for Q2 2025, and $2.7 million during Q1 2025.